REVA Medical Inc., a San Diego-based developer of bioresorbable stents to treat arterial disease, has filed for a $63 million IPO in Australia. Inteq Ltd. is serving as lead underwriter.
The company has raised around $57 million in VC funding, from groups like Domain Partners (21.6$ pre-IPO stake), Cerberus Capital Management (11.4%), Brookside Capital (11%) and Group Outcome (5.6%). www.teamreva.com
